Skip Navigation
Find a Doctor
 
 
 
 

 

Photo of Dr. Christine Hann

Christine Lee Hann, MD PhD

Assistant Professor of Oncology
Assistant Professor of Oncology
Female
Appointment Phone

410-955-8964

Main Location

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

View All Locations
Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-0773 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »

Titles

  • Assistant Professor of Oncology
  • Assistant Professor of Oncology

Centers & Institutes

  • Sidney Kimmel Comprehensive Cancer Center

Expertise

Lung Cancer, Medical Oncology

Research Interests

Small cell and non-small cell lung cancer; New drug development for lung cancer

Languages

  • English

Memberships

American Association for Cancer Research
American Society of Clinical Oncology

Clinical Trial Keywords

  • lung cancer

Additional Resources

Additional Resources +
  • Education +

    Training

    • Thomas Jefferson University (Philadelphia PA ) (2000)

    Residencies

    • The University of Chicago / Internal Medicine (Chicago IL ) (2002)

    Fellowships

    • Johns Hopkins University School of Medicine / Hematology and Oncology (Baltimore MD ) (2007)

    Certifications

    • American Board of Internal Medicine / Medical Oncology (2006)
  • Research & Publications +

    Selected Publications

    Research Summary:

    Dr. Hann is a member of the Upper Aerodigestive Cancer Program, with a primary focus on developing novel therapeutics for lung cancer, particularly small cell lung cancer. As a post-doctoral fellow, her research focused on the preclinical evaluation of a novel small molecule inhibitor which is currently in Phase I/II clinical trials.

    She is the recipient of several awards, including an ASCO Young Investigator Award and a FAMRI Young Clinical Scientist Award.

    As a faculty member, she sees patients with non-small cell and small cell lung cancer and conducts innovative research with both basic biological and major clinical implications.

    Current research projects in the lab include: 1) an evaluation of mechanisms of resistance to a small molecule inhibitor of Bcl-2 currently in clinical trials, 2) a preclinical evaluation of a novel anthracycline in a primary xenograft model of small cell lung cancer, and 3) the development of a small cell lung cancer-specific nanoparticle delivery system for gene therapy.

    Trainees in Dr. Hanns lab learn basic molecular biology techniques and approaches to preclinical evaluation of various therapeutic approaches to small cell lung cancer treatment.

    Journal Citations:

    Hann, C.L.; Brahmer, J.R. Who should receive epidermal growth factor receptor inhibitors for non-small cell lung cancer and when? Current treatment options in oncology. 2007 Feb;8(1):28-37.

    Hann, C.L.; Rudin, C.M. Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer. Trends in molecular medicine. 2007 Apr;13(4):150-157.

    Hann, C.L.; Streiff, M.B. Vena caval filters. In: Kitchens, C.S.; Alving, B.M.; Kessler, C.M., editors. 2nd ed, Consultative Hemostasis and Thrombosis. Philadelphia: Elsevier Press; 2007. p. 531-552.

    Hann, C.L.; Daniel, V.C.; Sugar, E.A.; Dobromilskaya, I.; Murphy, S.C.; Cope, L.; Lin, X.; Hierman, J.S.; Wilburn, D.L.; Watkins, D.N.; Rudin, C.M. Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. Cancer Res. 2008 Apr 1;68(7):2321-2328.

    Hann, C.L.; Rudin, C.M. Management of small-cell lung cancer: incremental changes but hope for the future. Oncology (Williston Park). 2008 Nov 30;22(13):1486-1492; discussion 1493-1486, 1498-1500, 1506.

    Rudin, C.M.; Hann, C.L.; Peacock, C.D.; Watkins, D.N. Novel systemic therapies for small cell lung cancer. J Natl Compr Canc Netw. 2008 Mar;6(3):315-322.

    Streiff, M.B.; Hann, C.L. Chapter 12: Inferior Vena Cava Ineterruption. In: Ginsberg, editor, Evidence-Based Hematology: British Medical Journal Publishing Group; 2008.

    Gallia, G.L.; Tyler, B.M.; Hann, C.L.; Siu, I.M.; Giranda, V.L.; Vescovi, A.L.; Brem, H.; Riggins, G.J. Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells. Molecular cancer therapeutics. 2009 Feb;8(2):386-393.

    Holdhoff, M.; Supko, J.G.; Gallia, G.L.; Hann, C.L.; Bonekamp, D.; Ye, X.; Cao, B.; Olivi, A.; Grossman, S.A. Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme. J Neurooncol. 2009 Sep 19;97(2):241-250.

    Rudin, C.M.; Hann, C.L.; Laterra, J.; Yauch, R.L.; Callahan, C.A.; Fu, L.; Holcomb, T.; Stinson, J.; Gould, S.E.; Coleman, B.; LoRusso, P.M.; Von Hoff, D.D.; de Sauvage, F.J.; Low, J.A. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. The New England journal of medicine. 2009 Sep 17;361(12):1173-1178.

    Von Hoff, D.D.; LoRusso, P.M.; Rudin, C.M.; Reddy, J.C.; Yauch, R.L.; Tibes, R.; Weiss, G.J.; Borad, M.J.; Hann, C.L.; Brahmer, J.R.; Mackey, H.M.; Lum, B.L.; Darbonne, W.C.; Marsters, J.C., Jr.; de Sauvage, F.J.; Low, J.A. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 2009 Sep 17;361(12):1164-1172.

    Yauch, R.L.; Dijkgraaf, G.J.; Alicke, B.; Januario, T.; Ahn, C.P.; Holcomb, T.; Pujara, K.; Stinson, J.; Callahan, C.A.; Tang, T.; Bazan, J.F.; Kan, Z.; Seshagiri, S.; Hann, C.L.; Gould, S.E.; Low, J.A.; Rudin, C.M.; de Sauvage, F.J. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science. 2009 Oct 23;326(5952):572-574.

    Hann, C.L. Managing Risk-What if My Cancer Comes Back?: Jones and Bartlett; 2010.

    Holdhoff, M.; Supko, J.G.; Gallia, G.L.; Hann, C.L.; Bonekamp, D.; Ye, X.; Cao, B.; Olivi, A.; Grossman, S.A. Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme. J Neurooncol. 2010 Apr;97(2):241-245.
  • Academic Affiliations & Courses +
  • Activities & Honors +

    Honors

    Young Clinical Scientist Award, Flight Attendant Medical Research Institute, 2007
    Pearl M. Stetler Fellowship Award for Women Physicians, Johns Hopkins University, 2006
    Young Investigator Award, American Society of Clinical Oncology, 2005
  • Videos & Media +

    Videos

    The Johns Hopkins Kimmel Cancer Center's Lung Cancer Multidisciplinary Clinic

    Learn about the Thoracic Oncology Multidisciplinary Clinic at the Johns Hopkins Kimmel Cancer Center. Our experts will discuss what to expect during your visit and offer treatment options and support.

    Meet Christine Hann, M.D., Ph.D.

    Hear from Christine Hann, M.D., Ph.D., assistant professor of oncology discuss her role in the Johns Hopkins Kimmel Cancer Center's Lung Cancer Multidisciplinary Lung Cancer Clinic

    Video Links

  • Events +
  • Contact & Locations +

    Locations

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    401 N. Broadway
    Baltimore, MD 21231
    Appointment Phone: 410-955-8964
    Location Map

    Department/Division

    • Oncology

Is This You? Edit Profile

 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.